International Biotechnology (LON:IBT) Share Price Crosses Above 200 Day Moving Average – Time to Sell?

International Biotechnology (LON:IBT) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 975.85 and traded as high as GBX 1,054.81. International Biotechnology shares last traded at GBX 1,045, with a volume of 95,171 shares trading hands.

International Biotechnology Stock Performance

The company has a market capitalization of £342.15 million, a price-to-earnings ratio of 4.45 and a beta of 0.52. The company has a debt-to-equity ratio of 9.43, a quick ratio of 0.32 and a current ratio of 0.11. The company’s fifty day simple moving average is GBX 1,045.80 and its two-hundred day simple moving average is GBX 976.40.

International Biotechnology (LON:IBT) last released its earnings results on Tuesday, May 12th. The company reported GBX (4.83) earnings per share for the quarter. International Biotechnology had a return on equity of 27.35% and a net margin of 82.27%.The company had revenue of GBX 24 million during the quarter. Equities research analysts predict that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.